Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

Newest hydroxychloroquine data ‘do not support’ use as COVID-19 treatment

This latest analysis compared the outcomes of hospitalized COVID-19 patients treated with hydroxychloroquine and those who received a placebo. 

Thumbnail

Marijuana use linked to worse outcomes for PCI, heart attack patients

PCI patients who used marijuana had an increased risk of bleeding events and stroke following the procedure.

Thumbnail

Among TAVR patients with AFib, DOACs lead to better survival rates than vitamin K antagonists

However, the two treatment options were associated with similar rates of long-term bleeding and ischemic events. 

Thumbnail

Risk of death, disability after stroke much higher for COVID-19 patients

Experiencing a stroke while your body is already battling COVID-19 can be especially dangerous, this new study suggests. 

Thumbnail

Just 6.9% of COVID-related clinical trials are focused on cardiovascular therapies

The study's authors looked at nearly 3,000 clinical trials related to the ongoing pandemic. 

Thumbnail

FDA announces another recall for extended-release metformin due to contamination

Nostrum Laboratories is at the center of this latest voluntary recall. 

Thumbnail

Cardiac resynchronization therapy benefits patients with severe LV dysfunction

No procedure-related deaths were reported, and an absolute LVEF improvement of more than 5% was present in nearly 49% of patients. 

New-look implantable device can identify, treat heart disease

The patch harvests energy from each heartbeat, allowing it to operate with no external power source. 

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.